专利号:US-2012177593-A1 优先权日:2009-07-20 标 题 :Synthesis of dendrimer conjugates 发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH 权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN 摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.
专利号:US-2012232225-A1 优先权日:2009-08-26 标 题:Synthesis and isolation of dendrimer systems 发明人:BAKER JR JAMES R; BANASZAK HOLL MARK M; MULLEN DOUGLAS GURNETT; ORR BRADFORD G; DESAI ANKUR; SANDER LEONARD M; WADDELL JACK NEEL 权利人:BAKER JR JAMES R; BANASZAK HOLL MARK M; MULLEN DOUGLAS GURNETT; ORR BRADFORD G; DESAI ANKUR; SANDER LEONARD M; WADDELL JACK NEEL; UNIV MICHIGAN 摘要:The present invention relates to novel methods of synthesis and isolation of dendrimer systems. In particular, the present invention is directed to novel dendrimer conjugates with defined and limited numbers of ligand conjugates and high levels of structural uniformity, methods of synthesizing the same, compositions comprising the conjugates, as well systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer) diagnosis and/or therapy, pain therapy, etc.)).
专利号:US-8338565-B2 优先权日:2008-08-20 标 题 :Macrocyclic compounds for inhibition of tumor necrosis factor alpha 发明人:LEE JINBO; BOND JULIAN F; TERRETT NICHOLAS; FAVALORO JR FRANK G; WANG DANIEL; BRIGGS TIMOTHY F; SEIGAL BENJAMIN ADAM; SUN WEI-CHUAN; HALE STEPHEN P 权利人:LEE JINBO; BOND JULIAN F; TERRETT NICHOLAS; FAVALORO JR FRANK G; WANG DANIEL; BRIGGS TIMOTHY F; SEIGAL BENJAMIN ADAM; SUN WEI-CHUAN; HALE STEPHEN P; ENSEMBLE THERAPEUTICS CORP 摘要:Disclosed herein are macrocyclic compounds and methods for their synthesis and use. In particular, macrocyclic compounds are disclosed that modulate the activity of tumor necrosis factor alpha and/or are useful in the treatment of medical conditions, such as, rheumatoid arthritis, psoriasis, and asthma.
专利号:WO-2011011384-A2 优先权日:2009-07-20 标 题 :Synthesis of dendrimer conjugates
专利号:WO-2011028334-A2 优先权日:2009-08-26 标题:Synthesis and isolation of dendrimer systems
专利号:US-2012259098-A1 优先权日:2009-10-13 标题 :Dendrimer compositions and methods of synthesis
1: Larif S, Slim R, Fathallah N, Ghariani N, Hmouda H, Salem CB. Lornoxicam-induced acute generalized exanthematous pustulosis. Int J Dermatol. 2016 Mar 11. doi: 10.1111/ijd.13252. [Epub ahead of print] doi: 10.1016/j.bjan.2015.11.003. Epub 2015 Nov 29. Portuguese. doi: 10.1016/j.bjane.2014.07.013. Epub 2015 Mar 29. doi: 10.1016/j.ijpharm.2015.07.010. Epub 2015 Jul 4. doi: 10.1097/MPA.0000000000000344. doi: 10.1016/j.ejogrb.2015.03.005. Epub 2015 Mar 9. doi: 10.1111/coa.12351. 9: Kotsovolis G, Karakoulas K, Grosomanidis V, Tziris N. Comparison between the combination of gabapentin, ketamine, lornoxicam, and local ropivacaine and each of these drugs alone for pain after laparoscopic cholecystectomy: a randomized trial. Pain Pract. 2015 Apr;15(4):355-63. doi: 10.1111/papr.12183. Epub 2014 Feb 27. doi: 10.1515/acph-2015-0009. doi: 10.1155/2015/545807. Epub 2015 Aug 31. 12: Kilbaş Z, Menteş MÖ, Harlak A, Yiğit T, Balkan SM, Coşar A, Öztürk E, Kozak O, Tufan CT. Efficacy of wound infiltration with lornoxicam for postoperative analgesia following thyroidectomy: a prospective, randomized, double-blind study. Turk J Med Sci. 2015;45(3):700-5. doi: 10.3109/08982104.2014.941861. Epub 2014 Jul 24. doi: 10.3109/10717544.2014.885615. Epub 2014 Feb 13. doi: 10.5414/CP202190. doi: 10.1007/s10517-014-2680-0. Epub 2014 Nov 19. doi: 10.1111/pme.12536. Epub 2014 Aug 19. doi: 10.3109/03639045.2013.804834. Epub 2013 Jul 5. doi: 10.1002/jps.24073. Epub 2014 Jul 3.
合成参考文献
参考文献:10.1016/j.jpba.2011.06.012 摘要:Modhave DT, Handa T, Shah RP, Singh S. Stress degradation studies on lornoxicam using LC, LC–MS/TOF and LC–MSn. Journal of Pharmaceutical and Biomedical Analysis. 2011 Nov;56(3):538–45. doi: 10.1016/j.jpba.2011.06.012. 参考文献:10.1159/000327658 摘要:Tuzuner Oncul AM, Yazicioglu D, Alanoglu Z, Demiralp S, Ozturk A, Ucok C. Postoperative analgesia in impacted third molar surgery: the role of preoperative diclofenac sodium, paracetamol and lornoxicam. Med Princ Pract. 2011;20(5):470–6. doi: 10.1159/000327658.